Clinical Trial Update: MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial of MT-8554 in postmenopausal women aimed to reduce vasomotor symptoms (hot flashes); the study has completed and results were posted in January 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• MT-8554

Snippet

Sponsor: Tanabe Pharma America, Inc. | Conditions: Menopause Hot Flashes | Phase 2 | Status: COMPLETED | Results posted: 2022-01-04